Login to Your Account



Singapore’s Aslan Gets Cash Injection of $22M in Series B

By Shannon Ellis
Staff Writer

Friday, October 18, 2013
SHANGHAI – A cash injection will help an innovative Singapore drug developer to push forward its gastric cancer drug while strengthening its pipeline.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription